Ra Capital Management, L.P. - Mar 27, 2024 Form 3 Insider Report for Boundless Bio, Inc. (BOLD)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
BOLD
Transactions as of
Mar 27, 2024
Transactions value $
$0
Form type
3
Date filed
3/27/2024, 08:16 PM
Previous filing
Mar 27, 2024
Next filing
Apr 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BOLD Series B Preferred Stock Mar 27, 2024 Common Stock 872K See footnotes F1, F2, F3
holding BOLD Series B Preferred Stock Mar 27, 2024 Common Stock 154K See footnotes F1, F3, F4
holding BOLD Series C Preferred Stock Mar 27, 2024 Common Stock 716K See footnotes F1, F2, F3
holding BOLD Series C Preferred Stock Mar 27, 2024 Common Stock 126K See footnotes F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock and Series C Preferred Stock will automatically convert into shares of Common Stock on a 19.5-for-1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
F2 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F4 Held directly by Nexus Fund II.